Effect of stent in pancreatic duct for preventing pancreatitis complications

Effect of pancreatic duct stenting before common bile duct (CBD) cannulation for preventing post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients attending in Firoozgar hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201201018575N1

Enrollment

Registered

2013-06-24

Start date

2012-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Bile Duct (CBD) stone. Calculus of bile duct without cholangitis or cholecystitis

Interventions

Intervention 1: In the intervention group, according to the accidental cannulation of pancreatic duct, a plastic stent 5cm and 5f (French) is placed in the pancreatic duct, and then ERCP will be done.

Prevention

In the intervention group, according to the accidental cannulation of pancreatic duct, a plastic stent 5cm and 5f (French) is placed in the pancreatic duct, and then ERCP will be done. In the control

In the control group, standard ERCP without stenting is done, and the results would be compared with the case group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria are: 1- Difficult cannulation that takes more than 15 minutes time; 2- Precut in vater ampulla while endoscopic retrograde cholangiopancreatography (ERCP); 3- Oddi sphincter dysfunction; 4- Three times duct catheterization with guide; 5- One time duct catheterization with catheter; 6- Duct contrast injection for patients who had at least one above criteria. The main exclusion criteria are patients who have pancreatitis before intervention. In this situation, the diagnosis of induced pancreatitis from ERCP is difficult.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pancreatitis. Timepoint: Patient's Amylase: 1- before ERCP. 2- during 6 and 18 hours after ERCP / after ERCP symptoms in patients are examined and investigated by a physician. Method of measurement: According to serum amylase measurement and symptoms such as abdominal pain.;Putting stents in the pancreatitis duct. Timepoint: While bile duct cannulation in patients having inclusion criteria. Method of measurement: Intraoperative observation.	—

Measure

Time frame

Pancreatitis. Timepoint: Patient's Amylase: 1- before ERCP. 2- during 6 and 18 hours after ERCP / after ERCP symptoms in patients are examined and investigated by a physician. Method of measurement: According to serum amylase measurement and symptoms such as abdominal pain.;Putting stents in the pancreatitis duct. Timepoint: While bile duct cannulation in patients having inclusion criteria. Method of measurement: Intraoperative observation.

—

Secondary

Measure	Time frame
Serum amylase. Timepoint: Before ERCP, within 6 and 18 hours post ERCP. Method of measurement: The patients' blood sampling (Mg/ dl).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Ajdarkosh

Firoozgar Hospital

ajdarkosh1345@yahoo.com+98 21 8214 1633

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026